However, studies have revealed that hypopharyngeal carcinoma cells frequently exhibit Bcl-2 overexpression and Bax downregulation, resulting in impaired apoptotic signaling and significantly enhanced cisplatin resistance. Here, BCL2 is linked to hypopharyngeal carcinoma.